Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01270919 · ClinicalTrials.gov registry record · NA
A Prospective, Post-market, Multi-center Feasibility Study of the BioDuct® Meniscal Repair Device
A NA study, sponsored by Stryker Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01270919 is a NA study that was terminated before completion, run by Stryker Orthopaedics. The registered enrollment target is 1 participants.
The verdict
NCT01270919, a NA study, was terminated before completion, sponsored by Stryker Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
To demonstrate repair of the meniscus at 6 months, as evaluated by MRI, will be observed; and clinical qualitative assessments will improve from preoperative to postoperative time points with the BioDuct® Meniscal Repair Device.
Interventions
- DEVICE BioDuct Meniscal Repair Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01270919
The ClinicalTrials.gov registry entry for NCT01270919 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BioDuct Meniscal Repair Device is the first listed.
NCT01270919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01270919 about?
NCT01270919 is a clinical study titled "A Prospective, Post-market, Multi-center Feasibility Study of the BioDuct® Meniscal Repair Device". To demonstrate repair of the meniscus at 6 months, as evaluated by MRI, will be observed; and clinical qualitative assessments will improve from preoperative to postoperative time points with the BioDuct® Meniscal Repair Device.
What is the current status of trial NCT01270919?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2010-11. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01270919?
The interventions under investigation include: BioDuct Meniscal Repair Device (DEVICE).
Who is sponsoring clinical trial NCT01270919?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.